Patents by Inventor Nicolas Babault

Nicolas Babault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Products useful for the treatment of malignant neoplasms of the human nervous system
    Patent number: 9234005
    Abstract: The application provides products, which may trigger pro-apoptotic or pro-death effects on neoplastic cells and/or tissues of the human nervous system, more particularly on neoplastic cells and/or tissues of the human CNS. The products of the application can be used as anti-proliferative or tumoricid agents in the treatment and/or palliation and/or prevention of neoplasms of the human nervous system, more particularly of glioblastoma or brain stem glioma. Therefore, the application also relates to compositions, such as pharmaceutical compositions or drugs, which comprise at least one of said products, as well as to the biotechnological and medical applications of said products and compositions.
    Type: Grant
    Filed: October 11, 2012
    Date of Patent: January 12, 2016
    Assignees: INSTITUT PASTEUR, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE PIERRE ET MARIE CURIE PARIS
    Inventors: Nicolas Wolff, Monique Lafon, Nicolas Babault
  • PRODUCTS USEFUL FOR THE TREATMENT OF MALIGNANT NEOPLASMS OF THE HUMAN NERVOUS SYSTEM
    Publication number: 20140302123
    Abstract: The application provides products, which may trigger pro-apoptotic or pro-death effects on neoplastic cells and/or tissues of the human nervous system, more particularly on neoplastic cells and/or tissues of the human CNS. The products of the application can be used as anti-proliferative or tumoricid agents in the treatment and/or palliation and/or prevention of neoplasms of the human nervous system, more particularly of glioblastoma or brain stem glioma. Therefore, the application also relates to compositions, such as pharmaceutical compositions or drugs, which comprise at least one of said products, as well as to the biotechnological and medical applications of said products and compositions.
    Type: Application
    Filed: October 11, 2012
    Publication date: October 9, 2014
    Inventors: Nicolas Wolfe, Monique Lafon, Nicolas Babault